Studies over the past couple of years have started to uncover complex genetic and epigenetic mechanisms regulating MYC expression, stability, and function in cancer, including lymphomas [29]–[32], and interrogation of these might shed light on the mechanisms underlying MYC overexpression in CNS DLBCL. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.